GIM
CRBU icon

Granahan Investment Management’s Caribou Biosciences CRBU Stock Holding History

Granahan Investment Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73,192
Closed -$376K – 184
2024
Q1 		$376K Sell
73,192
-65,138
-47% -$402K 0.01% 178
2023
Q4 		$793K Buy
138,330
+1,952
+1% +$9.65K 0.03% 171
2023
Q3 		$652K Buy
136,378
+10,081
+8% +$62.5K 0.02% 173
2023
Q2 		$537K Buy
126,297
+4,647
+4% +$20.9K 0.02% 170
2023
Q1 		$646K Sell
121,650
-108,691
-47% -$677K 0.02% 160
2022
Q4 		$1.45M Sell
230,341
-7,863
-3% -$70K 0.04% 163
2022
Q3 		$2.51M Sell
238,204
-210,851
-47% -$1.96M 0.08% 154
2022
Q2 		$2.44M Buy
449,055
+162,383
+57% +$1.24M 0.08% 154
2022
Q1 		$2.63M Buy
286,672
+204,545
+249% +$2.16M 0.07% 162
2021
Q4 		$1.24M Sell
82,127
-59,824
-42% -$1.16M 0.03% 181
2021
Q3 		$3.39M Buy
+141,951
New +$3.47M 0.06% 171

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Granahan Investment Management's CRBU Position: Q2 2024 in Review

Granahan Investment Management sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 73,192 shares — an estimated $376K sold.

Granahan Investment Management first reported a position in CRBU in Q3 2021 and held it in 11 quarters. The position peaked at $3.39M in Q3 2021. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

  • Granahan Investment Management reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
  • Granahan Investment Management sold 73,192 Caribou Biosciences shares in Q2 2024, an estimated $376K.
  • Granahan Investment Management first reported a position in Caribou Biosciences in Q3 2021 and held it in 11 quarters.
  • Granahan Investment Management's Caribou Biosciences position peaked at $3.39M in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on Granahan Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.